Berghoff, Anna S <br/><br/>
Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?  [electronic resource] 

 -  Nature reviews. Neurology  Jun 2019 
 - 314-315 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>1759-4766 
<br/><br/><label>Standard No.: </label>10.1038/s41582-019-0178-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies--therapeutic use<br/>Brain Neoplasms--immunology<br/>Glioblastoma--immunology<br/>Humans<br/>Immunotherapy--methods<br/>Neoadjuvant Therapy--methods<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Treatment Outcome